- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Adenocarcinoma in Norway
Total 147 results
-
Oslo University HospitalRecruitingMetastatic Colorectal Cancer | Cholangiocarcinoma | Pancreas AdenocarcinomaNorway
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsActive, not recruitingChemotherapy Effect | Locally Advanced Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic Adenocarcinoma | PancreatectomyNorway
-
University Hospital, AkershusOslo University Hospital; St. Olavs HospitalRecruitingColorectal Adenocarcinoma | Mucinous Adenocarcinoma | Signet Ring Cell AdenocarcinomaNorway
-
Haukeland University HospitalCompleted
-
Clavis PharmaCompletedAdvanced Adenocarcinoma of PancreasNorway, Belgium
-
Oslo University HospitalRecruitingIntrahepatic CholangiocarcinomaNorway
-
Lund University HospitalActive, not recruitingResectable Gastric and Gastroesophageal Junction AdenocarcinomaSweden, Norway
-
Oslo University HospitalRecruitingIntrahepatic Cholangiocarcinoma | Chemotherapy EffectNorway
-
Flemming ForsbergNational Cancer Institute (NCI)RecruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Ductal Adenocarcinoma | Unresectable...United States, Norway
-
Haukeland University HospitalUllevaal University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark and other collaboratorsCompletedNeuroendocrine CarcinomaNorway
-
Oslo University HospitalThe Research Council of NorwayRecruitingMesothelioma | Pseudomyxoma Peritonei | Colorectal Carcinoma | Ovarian CarcinomaNorway
-
Oslo University HospitalUnknown
-
Oslo University HospitalRecruitingBile Duct Cancer | Klatskin Tumor | Perihilar CholangiocarcinomaNorway
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedCarcinoma, Pancreatic DuctalNorway
-
Imperial College LondonPelican Cancer FoundationRecruiting
-
Oslo University HospitalCompletedRenal Cell Carcinoma | Urothelial Carcinoma | Renal Stone | Renal CystNorway
-
Trio Medicines Ltd.Norwegian University of Science and TechnologyTerminatedChronic Atrophic Gastritis | Hypergastrinemia | Type I Gastric CarcinoidsNorway
-
Sykehuset i Vestfold HFOslo University Hospital; Helse Sor-Ost; University of Geneva, Switzerland; Car...RecruitingQuality of Life | Small Bowel Cancer | Lymph Node Metastases | Small Bowel Carcinoid Tumor | Tumor MetastasisNorway
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Norway
-
Oslo University HospitalThe Research Council of Norway; St. Olavs HospitalActive, not recruitingStage I Breast Cancer | Stage II Breast Cancer | DCIS Grade 3 | LCIS, Lobular Carcinoma in SituNorway
-
Erasmus Medical CenterDutch Cancer Society; Dutch Pancreatic Cancer GroupRecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Resectable Pancreatic AdenocarcinomaNetherlands, Sweden, Norway
-
University of Medicine and Pharmacy CraiovaOdense University Hospital; University of Bergen; University College, London; University... and other collaboratorsCompletedChronic Pancreatitis | Adenocarcinoma PancreasDenmark, France, Germany, Italy, Norway, Romania, Spain, United Kingdom
-
BerGenBio ASAMerck Sharp & Dohme LLCCompletedLung Cancer Metastatic | Adenocarcinoma of Lung | NSCLC Stage IVUnited States, Spain, United Kingdom, Norway
-
Oslo University HospitalRecruitingClear Cell Renal Cell Carcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Melanoma Stage IV | Cutaneous Squamous Cell Carcinoma | MSI-HighNorway
-
University of Medicine and Pharmacy CraiovaOdense University Hospital; University of Bergen; University of Witten/Herdecke; Newcastle-upon-Tyne Hospitals NHS Trust and other collaboratorsCompletedPancreatic Adenocarcinoma | Chronic PancreatitisUnited Kingdom, Denmark, Italy, France, Germany, Belgium, Netherlands, Norway, Romania, Spain
-
Active Biotech ABCompletedRenal Cell Carcinoma | Pancreatic Cancer | Non-Small-Cell Lung CarcinomaUnited States, Norway, United Kingdom
-
Commissariat A L'energie AtomiqueAssistance Publique - Hôpitaux de ParisUnknownHepatocellular CarcinomaFrance
-
PCI Biotech ASCompletedCholangiocarcinomaGermany, France, Norway, United Kingdom
-
MedImmune LLCCompletedCarcinoma | Metastatic Pancreatic AdenocarcinomaUnited States, Spain, Australia, Norway
-
Translational Drug DevelopmentTranslational Genomics Research InstituteActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Nuvance HealthRecruitingPancreatic Neoplasms | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IV | Pancreatic Cancer Stage IIIUnited States
-
Ikena OncologyGilead SciencesTerminatedBreast Cancer | Head and Neck Cancer | Gynecologic Cancer | Colorectal Cancer | Pancreatic Cancer | Gastric Adenocarcinoma | Lung Adenocarcinoma | Advanced Solid TumorUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditionsUnited States, Puerto Rico
-
Boehringer IngelheimCompletedLung NeoplasmsHong Kong, Korea, Republic of, Spain, Singapore, China, United Kingdom, Taiwan, Canada, Australia, Germany, Ireland, Sweden, France, Norway
-
Clovis Oncology, Inc.CompletedMetastatic Pancreatic AdenocarcinomaUnited States, Belgium, Canada, Australia, United Kingdom, Germany, Italy, Argentina, Russian Federation, France, Brazil, Sweden, Norway, Netherlands, Ukraine
-
European Organisation for Research and Treatment...Active, not recruitingGastric and Esophagogastric Junction AdenocarcinomaUnited Kingdom, Italy, France, Spain, Germany, Czechia, Israel, Norway, Poland
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaUnited States, China, Hungary, Taiwan, Belgium, Germany, Spain, Italy, Czechia, France, Japan, Switzerland, Australia, Israel, Korea, Republic of, Canada, Russian Federation, Slovakia, United Kingdom, Turkey, Sweden, Greece, Finland, ... and more
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingRecurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Endometrial Serous Adenocarcinoma | Recurrent Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell... and other conditionsUnited States, Canada
-
Pharmacyclics LLC.CompletedMetastatic Pancreatic AdenocarcinomaSpain, Italy, Korea, Republic of, United States, Belgium, United Kingdom, Germany, France
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterRecruitingEndometrial Cancer | Endometrioid Adenocarcinoma | Endometrial Cancer Stage IUnited States, Czechia, Italy, Norway
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Dedifferentiated Carcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Recurrent Endometrial Adenocarcinoma | Recurrent Endometrial... and other conditionsUnited States, Korea, Republic of, Canada, Puerto Rico, Japan
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Cancer and Leukemia Group B; North Central...Active, not recruitingBreast AdenocarcinomaUnited States, Peru, South Africa
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States, Canada, Puerto Rico, Korea, Republic of, Japan
-
PCI Biotech ASTerminatedCholangiocarcinomaUnited States, Spain, Belgium, Germany, Italy, Denmark, Finland, France, Korea, Republic of, Norway, Poland, Sweden, Taiwan, Ukraine
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous... and other conditionsUnited States, Korea, Republic of, Canada, Japan
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownObesity | Fatigue | Stage I Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Neurotoxicity SyndromeUnited States, Korea, Republic of
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Esophageal Carcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Stage IV Esophageal Cancer AJCC v7 | Metastatic Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Recurrent Esophageal Adenocarcinoma and other conditionsUnited States
-
Cantargia ABActive, not recruitingColorectal Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal AdenocarcinomaAustria, Denmark, Germany, Belgium, Spain, Latvia, Netherlands, Lithuania, Estonia, Sweden, Norway
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma | Stage IV Prostate AdenocarcinomaUnited States, Canada